ENCOMPASS HEALTH CORP's ticker is EHC and the CUSIP is 29261A100. A total of 387 filers reported holding ENCOMPASS HEALTH CORP in Q2 2018. The put-call ratio across all filers is 0.70 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,969 | -8.0% | 29,315 | -7.3% | 0.01% | 0.0% |
| Q2 2023 | $2,141 | +23.3% | 31,615 | -1.5% | 0.01% | +16.7% |
| Q1 2023 | $1,737 | -32.2% | 32,104 | -25.1% | 0.01% | -33.3% |
| Q4 2022 | $2,562 | -99.9% | 42,839 | +0.0% | 0.01% | +28.6% |
| Q3 2022 | $1,937,000 | +3.8% | 42,819 | +2.3% | 0.01% | 0.0% |
| Q2 2022 | $1,866,000 | -39.9% | 41,861 | -4.2% | 0.01% | -30.0% |
| Q1 2022 | $3,106,000 | +1001.4% | 43,677 | +972.6% | 0.01% | +900.0% |
| Q4 2019 | $282,000 | -23.2% | 4,072 | -29.9% | 0.00% | -50.0% |
| Q3 2019 | $367,000 | +29.7% | 5,805 | +29.8% | 0.00% | +100.0% |
| Q2 2019 | $283,000 | -18.0% | 4,473 | -24.2% | 0.00% | -50.0% |
| Q1 2019 | $345,000 | -57.2% | 5,899 | -54.9% | 0.00% | -50.0% |
| Q4 2018 | $806,000 | -56.4% | 13,069 | -44.9% | 0.00% | -50.0% |
| Q3 2018 | $1,849,000 | +28.4% | 23,722 | +11.6% | 0.01% | +33.3% |
| Q2 2018 | $1,440,000 | – | 21,263 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BARINGTON CAPITAL GROUP, L.P. | 76,809 | $4,155,367 | 5.68% |
| Paradice Investment Management LLC | 850,583 | $46,016,540 | 3.50% |
| BERNZOTT CAPITAL ADVISORS | 273,702 | $14,807,278 | 3.06% |
| Orchard Capital Management, LLC | 135,466 | $7,328,711 | 2.45% |
| Advantage Alpha Capital Partners LP | 202,232 | $10,940,751 | 2.28% |
| REINHART PARTNERS, LLC. | 746,588 | $40,390,419 | 2.19% |
| Magnetar Financial LLC | 1,917,030 | $103,711,323 | 2.02% |
| Leeward Investments, LLC - MA | 700,894 | $37,918,365 | 1.73% |
| HEARTLAND ADVISORS INC | 505,204 | $27,331,536 | 1.69% |
| Copeland Capital Management, LLC | 1,226,985 | $66,380 | 1.56% |